Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

336 ARTÍCULOS , VIENDO DEL 286 AL 300

Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits

Di Domenico F, Coccia R, Butterfield DA, Perluigi M.

Biochim Biophys Acta. 2011 Dec;1814(12):1785-95. doi: 10.1016/j.bbapap.2011.10.001. Epub 2011 Oct 12.

Challenges in the development of companion diagnostics for neuropsychiatric disorders

Nikolcheva T, Jäger S, Bush TA, Vargas G.

Expert Rev Mol Diagn. 2011 Nov;11(8):829-37. doi: 10.1586/erm.11.67.

Evolution of the diagnostic criteria for degenerative and cognitive disorders

Lopez OL, McDade E, Riverol M, Becker JT.

Curr Opin Neurol. 2011 Dec;24(6):532-41. doi: 10.1097/WCO.0b013e32834cd45b.

Molecular PET imaging in multicenter Alzheimer's therapeutic trials: current trends and implementation strategies

Seibyl J, Zubal IG, Jennings D, Marek K, Doraiswamy PM.

Expert Rev Neurother. 2011 Dec;11(12):1783-93. doi: 10.1586/ern.11.168.

The future of Alzheimer's disease: the next 10 years

Hampel H, Prvulovic D, Teipel S, Jessen F, Luckhaus C, Frölich L, Riepe MW, Dodel R, Leyhe T, Bertram L, Hoffmann W, Faltraco F; German Task Force on Alzheimer's Disease (GTF-AD).

Prog Neurobiol. 2011 Dec;95(4):718-28. doi: 10.1016/j.pneurobio.2011.11.008. Epub 2011 Nov 22.

Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants

Mayeux R, Schupf N.

Neurobiol Aging. 2011 Dec;32 Suppl 1(Suppl 1):S10-9. doi: 10.1016/j.neurobiolaging.2011.09.004.

Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia

Klunk WE.

Neurobiol Aging. 2011 Dec;32 Suppl 1(Suppl 1):S20-36. doi: 10.1016/j.neurobiolaging.2011.09.006.

Potential of functional MRI as a biomarker in early Alzheimer's disease

Sperling R.

Neurobiol Aging. 2011 Dec;32 Suppl 1(Suppl 1):S37-43. doi: 10.1016/j.neurobiolaging.2011.09.009.

Alliance for aging research AD biomarkers work group: structural MRI

Jack CR Jr.

Neurobiol Aging. 2011 Dec;32 Suppl 1(0 1):S48-57. doi: 10.1016/j.neurobiolaging.2011.09.011.

Changes in cognition

Albert MS.

Neurobiol Aging. 2011 Dec;32 Suppl 1(0 1):S58-63. doi: 10.1016/j.neurobiolaging.2011.09.010.

Conjugated polymers for enhanced bioimaging

Klingstedt T, Nilsson KP.

Biochim Biophys Acta. 2011 Mar;1810(3):286-96. doi: 10.1016/j.bbagen.2010.05.003. Epub 2010 May 13.

The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease

Mitchell RA, Herrmann N, Lanctôt KL.

CNS Neurosci Ther. 2011 Oct;17(5):411-27. doi: 10.1111/j.1755-5949.2010.00161.x. Epub 2010 Jun 16.

Can the CAMCOG be a good cognitive test for patients with Alzheimer's disease with low levels of education?

Aprahamian I, Martinelli JE, Cecato J, Izbicki R, Yassuda MS.

Int Psychogeriatr. 2011 Feb;23(1):96-101. doi: 10.1017/S104161021000116X. Epub 2010 Aug 3.

Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality

Ballard C, Creese B, Corbett A, Aarsland D.

Expert Opin Drug Saf. 2011 Jan;10(1):35-43. doi: 10.1517/14740338.2010.506711. Epub 2010 Aug 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias